Artax Biopharma is on a mission to develop new drug candidates which reset the body’s autoimmune system to give normal, healthy responses again in patients with T cell mediated autoimmune diseases.

1 in 10 individuals is affected by autoimmune disease – our mission is to treat them

Autoimmune diseases affect many of us, and we currently lack treatments which restore a more normal autoimmune response without causing immune suppression. Artax Biopharma aims to fill this gap with its pipeline of Nck modulators.

Need more information and insights? Get in touch with our team.

This field is for validation purposes and should be left unchanged.